BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND AXIN1, LA16c-314G4_3, 8312, ENSG00000103126, O15169, AXIN, MGC52315 AND Prognosis
3031 results:

  • 1. [Identification of key genes in Wilms tumor based on high-throughput RNA sequencing and their impacts on prognosis and immune responses].
    Gao Z; Lin J; Hong P; Hu Z; Dong J; Shi Q; Tian X; Liu F; Wei G
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):727-738. PubMed ID: 38708507
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A retrospective clinical analysis of 11 cases of PEComa from different sites.
    Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
    World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Establishment and validation of a nomogram for predicting overall survival of upper-tract urothelial carcinoma with bone metastasis: a population-based study.
    Hu J; Gu H; Zhang D; Wen M; Yan Z; Song B; Xie C
    BMC Urol; 2024 Apr; 24(1):100. PubMed ID: 38689213
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A novel pyroptosis-related gene signature exhibits distinct immune cells infiltration landscape in Wilms' tumor.
    Guo Y; Lu W; Zhang Z; Liu H; Zhang A; Zhang T; Wu Y; Li X; Yang S; Cui Q; Li Z
    BMC Pediatr; 2024 Apr; 24(1):279. PubMed ID: 38678251
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The survival benefit of metastasectomy for metastatic non-clear cell renal cell carcinoma: a retrospective cohort study.
    Dai J; He B; Zhang Y; Zhang H; Hu X; Xu L; Ni Y; Zhang X; Sun G; Zeng H; Shen P; Liu Z
    World J Urol; 2024 Apr; 42(1):259. PubMed ID: 38662226
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. PSAT1 enhances the efficacy of the prognosis estimation nomogram model in stage-based clear cell renal cell carcinoma.
    Wang J; He X; Mi Y; Chen YQ; Li J; Wang R
    BMC Cancer; 2024 Apr; 24(1):463. PubMed ID: 38614981
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PMab-314: An Anti-Giant Panda Podoplanin Monoclonal Antibody.
    Ouchida T; Li G; Suzuki H; Yanaka M; Nakamura T; Handa S; Tanaka T; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2024 Apr; 43(2):53-58. PubMed ID: 38593441
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Impact of perioperative blood transfusion on prognosis after nephrectomy in patients with renal cell carcinoma: A meta-analysis and systematic review.
    Xu J; Bai J; Pan H; Zhou Z
    Medicine (Baltimore); 2024 Apr; 103(14):e37646. PubMed ID: 38579099
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. External validation of a four-tiered grading system for chromophobe renal cell carcinoma.
    Liu S; Hou M; Yao Y; Mei J; Sun L; Zhang G
    Clin Exp Med; 2024 Mar; 24(1):61. PubMed ID: 38554222
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Recurrence of locally invasive retroperitoneal dedifferentiated liposarcoma shortly after surgery: A case report and literature review.
    Hu X; Han B; Yang Q; Li Q; Xiao D; Xu X
    Medicine (Baltimore); 2024 Mar; 103(13):e37604. PubMed ID: 38552050
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Nomogram for personalized prognostic assessment of children with favorable histology Wilms tumor: A retrospective analysis.
    Wang Z; Li J; Liu P; Xie X; Song H; Zhang W
    Urol Oncol; 2024 Jun; 42(6):178.e1-178.e10. PubMed ID: 38522976
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Bioinformatics analysis highlights CCNB1 as a potential prognostic biomarker and an anti-kidney renal papillary cell carcinoma drug target.
    Gong X; Gong Y; Wu G; Ke H
    Medicine (Baltimore); 2024 Mar; 103(12):e37609. PubMed ID: 38518000
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identification and validation of a novel signature based on macrophage marker genes for predicting prognosis and drug response in kidney renal clear cell carcinoma by integrated analysis of single cell and bulk RNA sequencing.
    Chen X; Zhang Z; Qin Z; Zhu X; Wang K; Kang L; Li C; Wang H
    Aging (Albany NY); 2024 Mar; 16(6):5676-5702. PubMed ID: 38517387
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
    Yang J; Xiang H; Cheng M; Jiang X; Chen Y; Zheng L; Yan S; Zhang S; Zhang C; Chen W; Chen D
    Neoplasma; 2024 Feb; 71(1):60-69. PubMed ID: 38506035
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The association between the triglyceride-glucose index and prognosis in postoperative renal cell carcinoma patients: a retrospective cohort study.
    Qin G; Sun Z; Jin Y; Ren X; Zhang Z; Wang S; Zhou G; Huang K; Zhao H; Jiang X
    Front Endocrinol (Lausanne); 2024; 15():1301703. PubMed ID: 38476671
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Comprehensive analysis of zinc and ring finger 3 in prognostic value and pan-cancer immunity.
    Liu M; Zhao H; Peng S; Wu Y; Liu Y; Sun W; Zen K; Sun X
    FASEB J; 2024 Mar; 38(5):e23523. PubMed ID: 38457275
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data.
    Erdem S; Bertolo R; Campi R; Capitanio U; Amparore D; Anceschi U; Mir MC; Roussel E; Pavan N; Carbonara U; Kara O; Klatte T; Marchioni M; Pecoraro A; Muselaers S; Marandino L; Diana P; Borregales L; Palumbo C; Warren H; Wu Z; Calio A; Ciccarese C; Degirmenci E; Aydin R; Rebez G; Schips L; Simone G; Minervini A; Serni S; Ozcan F
    Urol Oncol; 2024 May; 42(5):163.e1-163.e13. PubMed ID: 38443238
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Correlation of 1p/16q loss of heterozygosity and 1p gain with clinicopathological characteristics and prognosis in Wilms tumor].
    Jia C; Yao XF; Zhang M; Guan XX; Wang JW; Song HC; He LJ
    Zhonghua Bing Li Xue Za Zhi; 2024 Mar; 53(3):257-263. PubMed ID: 38433053
    [No Abstract]    [Full Text] [Related]  

  • 19. Impact of Tumor Grade Distribution on Genetic Alterations in Clear Cell Renal Cell Carcinoma and Prostate Cancer.
    Mizutani K; Sugiyama S; Kameyama K; Kamei S; Yokoi S; Morikawa A; Takeuchi M; Seike K; Yamada T; Ehara H; Sawada S; Hirade K; Furuta H; Matsunaga K; Yamada T; Sakamoto I; Kato Y; Nishihara H; Ishihara S; Deguchi T
    Cancer Genomics Proteomics; 2024; 21(2):203-212. PubMed ID: 38423595
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Elevated Plasma Concentration of 4-Pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR) Highlights Malignancy of Renal Cell Carcinoma.
    Jedrzejewska A; Jablonska P; Gawlik-Jakubczak T; Czajkowski M; Maszka P; Mierzejewska P; Smolenski RT; Slominska EM
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397036
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 152.